FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thilo Schlott

Research Profile

Chemicals & Drugs

Procedures

Disorders

Physiology

Genes & Molecular Sequences

Genes, Tumor Suppressor

Co-author Network

Publications

TOP 3
Thilo Schlott; Helmut Eiffert; Tyede H Schmidt-Schultz; Melanie Gebhardt; Hermann Parzinger; Michael Schultz
Detection and analysis of cancer genes amplified from bone material of a Scythian royal burial in Arzhan near Tuva, Siberia.
Ekkehard Kunze; Thilo Schlott
High frequency of promoter methylation of the 14-3-3 sigma and CAGE-1 genes, but lack of hypermethylation of the caveolin-1 gene, in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.
Ekkehard Kunze; Maike Wendt; Thilo Schlott
Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thilo Schlott (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Thilo Schlott; Helmut Eiffert; Tyede H Schmidt-Schultz; Melanie Gebhardt; Hermann Parzinger; Michael Schultz
Detection and analysis of cancer genes amplified from bone material of a Scythian royal burial in Arzhan near Tuva, Siberia.
Anticancer research 2007;27(6B):4117-9.
2007: Ekkehard Kunze; Thilo Schlott
High frequency of promoter methylation of the 14-3-3 sigma and CAGE-1 genes, but lack of hypermethylation of the caveolin-1 gene, in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder.
International journal of molecular medicine 2007;20(4):557-63.
2006: Ekkehard Kunze; Maike Wendt; Thilo Schlott
Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
International journal of molecular medicine 2006;18(4):547-57.
2006: Ulrich Brinck; Thilo Schlott; Steffi Störber; Jerzy Stachura; Pawel Bortkiewicz; Wolf-Dieter Nagel; Frank Michael Hasse; Carlos Cordon-Cardo; Gösta Fischer; Monika Korabiowska
Alterations of the retinoblastoma and p16 pathway correlate with promoter methylation in malignant fibrous histiocytomas.
Anticancer research 2006;26(5A):3461-5.
2006: Wolfgang E Thasler; Thilo Schlott; Arno Kalkuhl; Thomas Plän; Bernhard Irrgang; Karl-Walter Jauch; Thomas S Weiss
Human tissue for in vitro research as an alternative to animal experiments: a charitable "honest broker" model to fulfil ethical and legal regulations and to protect research participants.
Alternatives to laboratory animals : ATLA 2006;34(4):387-92.
2006: Ekkehard Kunze; Frederike von Bonin; Carola Werner; Maike Wendt; Thilo Schlott
Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
International journal of molecular medicine 2006;17(1):3-13.
2005: Helmut Eiffert; A Karsten; K Ritter; Andreas Ohlenbusch; Thilo Schlott; Rainer Laskawi; HJ Christen
Autoantibodies to human manganese superoxide dismutase (MnSOD) in children with facial palsy due to neuroborreliosis.
Neuropediatrics 2005;36(6):386-8.
2005: Thilo Schlott; Helmut Eiffert; Wolfgang Bohne; Jobst Landgrebe; Edgar Brunner; Bettina Spielbauer; Bryan Knight
Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue.
Gynecologic oncology 2005;98(3):409-19.
2005: Wolfgang E Thasler; Thilo Schlott; Paul Thelen; Claus Hellerbrand; F Bataille; M Lichtenauer; Hans J Schlitt; Karl-Walter Jauch; Thomas S Weiss
Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma.
Histopathology 2005;47(1):57-66.
2005: Markus Heuser; Thilo Schlott; Andrew V Schally; Elke Kahler; R Schliephake; SO Laabs; Bernhard Hemmerlein
Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion.
The Journal of urology 2005;173(6):2154-9.
2004: Monika Korabiowska; Thomas Quentin; Thilo Schlott; Hanne Bauer; Ekkehard Kunze
Down-regulation of Ku 70 and Ku 80 mRNA expression in transitional cell carcinomas of the urinary bladder related to tumor progression.
World journal of urology 2004;22(6):431-40.
2004: Monika Korabiowska; Thilo Schlott; Nils Siems; Anegret Müller; Carlos Cordon-Cardo; Gösta Fischer; Ulrich Brinck
Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(12):1539-44.
2004: Thilo Schlott; Helge Taubert; Afshin Fayyazi; Stefan Schweyer; Frank Bartel; Monika Korabiowska; Ulrich Brinck
Analysis of central regulatory pathways in p53-deficient primary cultures of malignant fibrous histiocytoma exposed to ifosfamide.
Anticancer research 2004;24(6):3819-29.
2004: Thilo Schlott; Thomas Quentin; Monika Korabiowska; Bettina Budd; Ekkehard Kunze
Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis.
International journal of molecular medicine 2004;14(5):825-36.
2004: Helmut Eiffert; A Karsten; Thilo Schlott; Andreas Ohlenbusch; Rainer Laskawi; Michael Hoppert; HJ Christen
Acute peripheral facial palsy in Lyme disease -- a distal neuritis at the infection site.
Neuropediatrics 2004;35(5):267-73.
2004: Andreas R Günthert; Carsten Gründker; Till Bongertz; Thilo Schlott; Attila Nagy; Andrew V Schally; Günter Emons
Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
American journal of obstetrics and gynecology 2004;191(4):1164-72.
2004: Thomas Quentin; Thilo Schlott; Monika Korabiowska; Nadine Käthei; Gerhard Zöller; Frank Glaser; Ekkehard Kunze
Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Anticancer research 2004;24(5A):2745-56.
2004: Stefan Schweyer; Afsaneh Soruri; O Meschter; A Heintze; Frank Zschunke; N Miosge; Paul Thelen; Thilo Schlott; Heinz-Joachim Radzun; Afshin Fayyazi
Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation.
British journal of cancer 2004;91(3):589-98.
2004: Afsaneh Soruri; Afshin Fayyazi; Stefanie Gangl; Christian Griesinger; Christian A Albrecht; Thilo Schlott
In vitro generation of cytolytic T cells against human melanoma cells overexpressing HDM2.
Anticancer research 2004;24(4):2141-51.
2004: Elisabeth Höcht-Zeisberg; Henning Kahnert; Kaomei Guan; Gerald Wulf; Bernhard Hemmerlein; Thilo Schlott; Gero Tenderich; Reiner Körfer; Ute Raute-Kreinsen; Gerd Hasenfuss
Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation.
European heart journal 2004;25(9):749-58.
2004: Thomas Quentin; Christian Henke; Monika Korabiowska; Thilo Schlott; Britt Zimmerman; Ekkehard Kunze
Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Anticancer research 2004;24(2B):1011-23.
2004: Monika Korabiowska; Fatima König; Raphaela Verheggen; Thilo Schlott; Carlos Cordon-Cardo; Bernd F.M. Romeike; Ulrich Brinck
Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Anticancer research 2004;24(2B):981-6.
2003: Helge Taubert; Katja Schuster; Ulrich Brinck; Frank Bartel; Matthias Kappler; Christine Lautenschläger; Matthias Bache; Cornelia Trump; Hannelore Schmidt; Hans-Jürgen Holzhausen; Peter Würl; Thilo Schlott
Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(11):1109-16.
2003: Benjamin Stürzenhofecker; Thilo Schlott; Thomas Quentin; Martin Hafner; Wolfram Jung; Lorenz Trümper
Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
Leukemia & lymphoma 2003;44(9):1587-96.
2003: Afsaneh Soruri; Joachim Riggert; Thilo Schlott; Ziba Kiafard; Claudia Dettmer; Jörg Zwirner
Anaphylatoxin C5a induces monocyte recruitment and differentiation into dendritic cells by TNF-alpha and prostaglandin E2-dependent mechanisms.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(5):2631-6.
2003: Holger Nagel; Rainer Laskawi; Helmut Eiffert; Thilo Schlott
Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.
Molecular pathology : MP 2003;56(4):226-31.
2002: Thilo Schlott; Wolfgang E Thasler; Carolin Gorzel; Sascha Pahernik; Ulrich Brinck; Helmut Eiffert; Manfred Droese
Detection of MDM2 alterations in cultured human hepatocytes treated with 17beta-estradiol or 17alpha-ethinylestradiol.
Anticancer research 2002;22(3):1545-51.
2002: Thilo Schlott; J G Scharf; C Gorzel; Peter Middel; Herbert Spring
Cirrhotic livers reveal genetic changes in the MDM2-P14ARF system of cell cycle regulators.
British journal of cancer 2002;86(8):1290-6.
2002: Monika Korabiowska; Carlos Cordon-Cardo; Herbert Betke; Thilo Schlott; M Kotthaus; Jerzy Stachura; Ulrich Brinck
GADD153 is an independent prognostic factor in melanoma: immunohistochemical and molecular genetic analysis.
Histology and histopathology 2002;17(3):805-11.
2001: Afsaneh Soruri; Afshin Fayyazi; C Neumann; Thilo Schlott; T Jung; C Matthes; Jörg Zwirner; Joachim Riggert; J Hinrich Peters
Ex vivo generation of human anti-melanoma autologous cytolytic T cells by dentritic cell/melanoma cell hybridomas.
Cancer immunology, immunotherapy : CII 2001;50(6):307-14.
2001: Thilo Schlott; J G Scharf; Afsaneh Soruri; Afshin Fayyazi; Christian Griesinger; C Albrecht; Helmut Eiffert; Manfred Droese
Fragments of human oncoprotein MDM2 reveal variable distribution within and on cultivated human hepatoma cells.
Biochemical and biophysical research communications 2001;283(4):956-63.
2001: Monika Korabiowska; M Viehöver; Thilo Schlott; H Berger; Manfred Droese; Ulrich Brinck
Relationship between DNA ploidy-related parameters and the deletions in mismatch repair genes MLH1 and MSH2 in lentigo maligna and malignant melanomas.
Archives of dermatological research 2001;293(5):219-25.
2001: Petra Ambrosch; Thilo Schlott; D Hilmes; Ilka Ruschenburg
p16 alterations and retinoblastoma protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract.
Virchows Archiv : an international journal of pathology 2001;438(4):343-9.
2001: Holger Nagel; Thilo Schlott; G M Schulz; Manfred Droese
Gene expression analysis of the catalytic subunit of human telomerase (hEST2) in the differential diagnosis of serous effusions.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2001;10(1):60-5.
2001: Monika Korabiowska; Ilka Ruschenburg; Thilo Schlott; A Kubitz; Ulrich Brinck; Manfred Droese
Relation between DNA ploidy status and the expression of the DNA-mismatch repair genes MLH1 and MSH2 in cytological specimens of melanoma lymph node and liver metastases.
Diagnostic cytopathology 2001;24(3):157-62.
2001: Monika Korabiowska; Ilka Ruschenburg; Herbert Betke; Jerzy Stachura; Thilo Schlott; C C Cardo; Ulrich Brinck
Downregulation of the retinoblastoma gene expression in the progression of malignant melanoma.
Pathobiology : journal of immunopathology, molecular and cellular biology 2001;69(5):274-80.
2001: Thilo Schlott; Holger Nagel; Rainer Laskawi; Helmut Eiffert; Manfred Droese
Genetic analysis of the human oncoprotein MDM2 in benign and malignant tumors of the salivary gland.
Pathobiology : journal of immunopathology, molecular and cellular biology 2001;69(2):67-76.
2000: Helge Taubert; Matthias Kappler; Axel Meye; Frank Bartel; Thilo Schlott; Christine Lautenschläger; Matthias Bache; Hannelore Schmidt; Peter Würl
A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility?
Mutation research 2000;456(1-2):39-44.
2000: Thilo Schlott; Peter Middel; Rainer Laskawi; Ulrich Brinck; Ilka Ruschenburg; Manfred Droese
Relationship between GAGE-1/-2 expression, EBV infection and interferon-gamma expression in undifferentiated carcinoma of nasopharyngeal type.
Anticancer research 2000;20(3A):1727-32.
1999: Ilka Ruschenburg; A Kubitz; Thilo Schlott; Monika Korabiowska; Manfred Droese
MAGE-1, GAGE-1/-2 gene expression in FNAB of classic variant of papillary thyroid carcinoma and papillary hyperplasia in nodular goiter.
International journal of molecular medicine 1999;4(4):445-8.
1999: Thilo Schlott; K Ahrens; Ilka Ruschenburg; S Reimer; H Hartmann; Manfred Droese
Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia.
British journal of cancer 1999;80(1-2):73-8.
1999: Monika Korabiowska; Ulrich Brinck; Ilka Ruschenburg; Thilo Schlott; Manfred Droese; Jerzy Stachura
Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation.
Polish journal of pathology : official journal of the Polish Society of Pathologists 1999;50(1):17-21.
1998: Ilka Ruschenburg; Monika Korabiowska; Thilo Schlott; A Kubitz; Manfred Droese
The value of PCR technique in fine needle aspiration biopsy of salivary gland for diagnosis of low-grade B-cell lymphoma.
International journal of molecular medicine 1998;2(3):339-41.
1998: Thilo Schlott; G Ruda; Michael Hoppert; Holger Nagel; S Reimer; I K Schumacher-Lütge; Manfred Droese
The in situ polymerase chain reaction for detection of chlamydia trachomatis.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1998;46(9):1017-23.
1998: Afsaneh Soruri; Afshin Fayyazi; Robert Gieseler; Thilo Schlott; Thomas M. Ruenger; C Neumann; J Hinrich Peters
Specific autologous anti-melanoma T cell response in vitro using monocyte-derived dendritic cells.
Immunobiology 1998;198(5):527-38.
1997: Ilka Ruschenburg; Thilo Schlott; B Linke; S Reimer; Manfred Droese
Automated molecular genetic DNA analysis for detecting B-cell non-Hodgkin's lymphoma in cytologic specimens.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1997;19(3):255-63.
1997: Thilo Schlott; S Reimer; A Jahns; Andreas Ohlenbusch; Ilka Ruschenburg; Holger Nagel; Manfred Droese
Point mutations and nucleotide insertions in the MDM2 zinc finger structure of human tumours.
The Journal of pathology 1997;182(1):54-61.
1997: Thilo Schlott; Holger Nagel; Ilka Ruschenburg; S Reimer; Manfred Droese
Reverse transcriptase polymerase chain reaction for detecting Ewing's sarcoma in archival fine needle aspiration biopsies.
Acta cytologica 1997;41(3):795-801.
1996: Ilka Ruschenburg; Thilo Schlott; Michael Kneba; S Reimer; Manfred Droese
[Cytological differential diagnosis of autoimmune thyroiditis and low malignancy non-Hodgkin's lymphoma of the thyroid gland using genetic analytic procedures].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1996;80():302.
1995: D Rössler; Helmut Eiffert; S Jauris-Heipke; Gisela Lehnert; V Preac-Mursic; J Teepe; Thilo Schlott; E Soutschek; Bettina Wilske
Molecular and immunological characterization of the p83/100 protein of various Borrelia burgdorferi sensu lato strains.
Medical microbiology and immunology 1995;184(1):23-32.
1993: M Scriba; J S Ebrahim; Thilo Schlott; Helmut Eiffert
The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies.
Infection and immunity 1993;61(10):4523-6.
1992: Helmut Eiffert; Thilo Schlott; Michael Hoppert; H Lotter; Reiner Thomssen
Identification of an endoflagellar associated protein in Borrelia burgdorferi.
Journal of medical microbiology 1992;36(3):209-14.